Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 908,838 | 1,064,432 | 1,233,032 | 1,227,252 | 1,113,496 |
| Marketable Securities | 141,688 | 80,618 | 38,839 | 48,277 | 58,582 |
| Receivables | 227,263 | 241,449 | 232,609 | 275,080 | 283,505 |
| Inventories | 16,623 | 13,144 | 10,965 | 12,143 | 14,881 |
| Other current assets | 258,846 | 226,809 | 182,316 | 166,584 | 233,379 |
| TOTAL | $1,621,570 | $1,695,145 | $1,760,498 | $1,772,876 | $1,751,148 |
| Non-Current Assets | |||||
| PPE Net | 527,623 | 533,706 | 534,381 | 538,421 | 542,702 |
| Investments And Advances | 124,142 | 120,988 | 62,819 | 54,155 | 42,188 |
| Intangibles | 498,019 | 465,701 | 463,584 | 467,599 | 475,179 |
| Other Non-Current Assets | 291,636 | 289,381 | 284,405 | 302,085 | 295,073 |
| TOTAL | $1,441,420 | $1,409,776 | $1,345,189 | $1,362,260 | $1,355,142 |
| Total Assets | $3,062,990 | $3,104,921 | $3,105,687 | $3,135,136 | $3,106,290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,373 | 19,104 | 17,779 | 12,187 | 8,385 |
| Accrued Expenses | 228,545 | 225,847 | 262,728 | 255,033 | 254,163 |
| Other current liabilities | 22,109 | 21,426 | 18,473 | 18,201 | 20,029 |
| TOTAL | $280,959 | $283,290 | $315,717 | $308,965 | $308,977 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 177,044 | 179,114 | 185,701 | 198,418 | 202,965 |
| TOTAL | $176,843 | $179,110 | $185,738 | $198,357 | $203,093 |
| Total Liabilities | $457,802 | $462,400 | $501,455 | $507,322 | $512,070 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 100,895 | 101,818 | 101,161 | 101,388 | 101,361 |
| Common Shares | 99 | 100 | 100 | 100 | 100 |
| Retained earnings | 2,615,354 | 2,649,175 | 2,607,909 | 2,626,447 | 2,591,870 |
| Other shareholders' equity | -10,265 | -6,754 | -3,777 | 1,267 | 2,250 |
| TOTAL | $2,605,188 | $2,642,521 | $2,604,232 | $2,627,814 | $2,594,220 |
| Total Liabilities And Equity | $3,062,990 | $3,104,921 | $3,105,687 | $3,135,136 | $3,106,290 |